Fluorescence Clinical Trials

2 recruiting

Fluorescence Trials at a Glance

7 actively recruiting trials for fluorescence are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Amersfoort, Chicago, and Guangzhou. Lead sponsors running fluorescence studies include Isabelle Henskens, Abramson Cancer Center at Penn Medicine, and Ann & Robert H Lurie Children's Hospital of Chicago.

Browse fluorescence trials by phase

Treatments under study

About Fluorescence Clinical Trials

Looking for clinical trials for Fluorescence? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fluorescence trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fluorescence clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)

Breast CancerMastectomySentinel Lymph Node Biopsy (SLNB)+7 more
Isabelle Henskens90 enrolled2 locationsNCT07362485
Recruiting
Not Applicable

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

Breast CancerSentinel Lymph Node Biopsy (SLNB)Sentinel Lymph Node Detection+6 more
Isabelle Henskens1,760 enrolled7 locationsNCT07146295
Recruiting
Early Phase 1

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Endometrial CancerNear Infrared Fluorescence ImagingCYTALUX (Pafolacianine) Injection+1 more
Abramson Cancer Center at Penn Medicine10 enrolled2 locationsNCT07278986
Recruiting
Not Applicable

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

Sentinel Lymph NodeIndocyanine Green (ICG)Colon Cancer+9 more
Meander Medical Center341 enrolled1 locationNCT06652672
Recruiting
Phase 3

Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)

Fluorescence-guided Resection5-aminolevulinic Acid
Lee's Pharmaceutical Limited144 enrolled2 locationsNCT06160492
Recruiting
Phase 1

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Metastatic SarcomaOsteosarcomaPulmonary Metastasis+2 more
Ann & Robert H Lurie Children's Hospital of Chicago10 enrolled1 locationNCT06235125
Recruiting
Not Applicable

Micro-dosing Indocyanine Green (ICG) in Children

Fluorescence ImagingPerfusionGastrointestinal Tract Disorders+1 more
Great Ormond Street Hospital for Children NHS Foundation Trust90 enrolled1 locationNCT06421103